Compare Aksara Global Development Tbk. (GAMA) vs Merck Tbk. (MERK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Aksara Global Development Tbk. vs Merck Tbk. — how do they compare? Aksara Global Development Tbk. trades at Rp18 (market cap 180.2B), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Merck Tbk. is far larger — about 9.8× Aksara Global Development Tbk.'s market cap. Which is the better fit depends on your goals.
| GAMA | MERK | |
|---|---|---|
Market Cap | 180.2B | 1.76T |
Volume | — | 63K |
Lot | — | 630 |
Turnover | — | 243.97M |
Average Price | — | 3,872.46 |
Value | — | 243.97M |
Indicative Equilibrium Price | — | 3,900 |
Indicative Equilibrium Volume | — | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Aksara Global Development Tbk.
PT Gading Development Tbk (formerly PT Artha Asia Pratama) was established based on notarial deed No. 45 dated December 18, 2003 of P. Sutrisno A. Tampubolon, S.H., M.Kn., notary in Jakarta.
Read more on GAMA →About Merck Tbk.
PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →
